SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spectrum Pharmaceuticals, Inc (SPPI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: barondog who wrote (32)9/7/2012 9:20:20 AM
From: bandit22_2000  Read Replies (1) of 41
 
I stopped reading when I got to that point. If they can't get the fact that Leuco has been in shortage for multiple years, then it's clear to me that they aren't someone I need to listen too.

So many of these articles talk as if the Leuco shortage is just this temporary thing and that one day Leuco will rain down from the heavens rendering Fusilev obsolete. It's pretty easy to figure out why that won't happen. When will the street realize it? I have no idea. That's why it's nice to have another revenue producing drug in the portfolio. Fusilev will keep doing what it does in the background while we focus on Folotyn growth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News